Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease
- PMID: 6603463
- DOI: 10.1038/jcbfm.1983.57
Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease
Abstract
Young normal subjects, old normal subjects, and patients with senile dementia of the Alzheimer's type (SDAT) were studied with both computed tomography (CT) and positron emission transaxial tomography (PETT). Increases in ventricular size with both aging and disease were measured. Regional glucose metabolic rate was not affected by age, but was markedly reduced in SDAT patients. These data indicate that in normal aging, structural brain changes may be more salient than biochemical changes. Although both structural and biochemical changes occur in SDAT, the biochemical changes are more marked. The results suggest that PETT is potentially more useful than CT in the in vivo diagnosis of SDAT.
Similar articles
-
Computed tomography findings in senile dementia and normal aging.J Neurol Neurosurg Psychiatry. 1982 Jan;45(1):50-4. doi: 10.1136/jnnp.45.1.50. J Neurol Neurosurg Psychiatry. 1982. PMID: 7062070 Free PMC article.
-
Correction of positron emission tomography data for cerebral atrophy.J Cereb Blood Flow Metab. 1986 Feb;6(1):120-4. doi: 10.1038/jcbfm.1986.14. J Cereb Blood Flow Metab. 1986. PMID: 3484745
-
Computed tomography in aging and senile dementia of the Alzheimer type.Adv Neurol. 1983;38:103-22. Adv Neurol. 1983. PMID: 6604399 No abstract available.
-
Single photon emission computed tomography in Alzheimer's disease and related disorders.Neuroimaging Clin N Am. 1995 Feb;5(1):103-23. Neuroimaging Clin N Am. 1995. PMID: 7743079 Review.
-
Normal and pathological aging--findings of positron-emission-tomography.J Neural Transm (Vienna). 1998;105(8-9):821-37. doi: 10.1007/s007020050097. J Neural Transm (Vienna). 1998. PMID: 9869321 Review.
Cited by
-
The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease.Curr Genomics. 2007 Dec;8(8):509-30. doi: 10.2174/138920207783769512. Curr Genomics. 2007. PMID: 19415126 Free PMC article.
-
Metabolic brain networks in aging and preclinical Alzheimer's disease.Neuroimage Clin. 2017 Dec 28;17:987-999. doi: 10.1016/j.nicl.2017.12.037. eCollection 2018. Neuroimage Clin. 2017. PMID: 29527500 Free PMC article.
-
Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment.Arch Neurol. 2010 Apr;67(4):440-6. doi: 10.1001/archneurol.2010.34. Arch Neurol. 2010. PMID: 20385910 Free PMC article.
-
Cerebral metabolism, anatomy, and cognition in monozygotic twins discordant for dementia of the Alzheimer type.J Neurol Neurosurg Psychiatry. 1987 Mar;50(3):333-40. doi: 10.1136/jnnp.50.3.333. J Neurol Neurosurg Psychiatry. 1987. PMID: 3494105 Free PMC article.
-
Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults.Neurobiol Aging. 2012 Dec;33(12):2723-32. doi: 10.1016/j.neurobiolaging.2012.01.014. Epub 2012 Mar 8. Neurobiol Aging. 2012. PMID: 22405043 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical